News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
333,319 Results
Type
Article (19705)
Company Profile (125)
Press Release (313489)
Section
Business (107481)
Career Advice (863)
Deals (19043)
Drug Delivery (83)
Drug Development (51528)
Employer Resources (79)
FDA (7762)
Job Trends (7795)
News (189458)
Policy (17771)
Tag
Academia (771)
Africa (421)
Alliances (28461)
Alzheimer's disease (527)
Antibody-drug conjugate (ADC) (39)
Approvals (7726)
Arizona (45)
Artificial intelligence (54)
Asia (24511)
Australia (3167)
Bankruptcy (172)
Best Places to Work (5425)
Biosimilars (57)
Biotechnology (60)
C2C Services and Suppliers (14278)
California (871)
Canada (544)
Cancer (256)
Cardiovascular disease (34)
Career advice (700)
Cell therapy (42)
China (84)
Clinical research (41855)
Collaboration (82)
Connecticut (31)
COVID-19 (1092)
Cystic fibrosis (43)
Data (169)
Diabetes (52)
Diagnostics (1760)
Drug pricing (73)
Earnings (38687)
Employer resources (71)
Europe (54019)
Events (48042)
Executive appointments (99)
FDA (7864)
Florida (110)
Funding (57)
Gene therapy (56)
GLP-1 (424)
Government (1867)
Healthcare (6174)
Hotbed/Location (222988)
Illinois (94)
Indiana (79)
Infectious disease (1112)
Inflammatory bowel disease (60)
Interviews (114)
IPO (7456)
Job creations (2442)
Job search strategy (648)
Kansas (54)
Layoffs (244)
Legal (4169)
Lung cancer (66)
Manufacturing (65)
Maryland (135)
Massachusetts (734)
Medical device (2246)
Medtech (2249)
Mergers & acquisitions (11508)
Metabolic disorders (212)
Minnesota (65)
Neuroscience (620)
New Jersey (341)
New York (258)
NextGen Class of 2024 (2383)
Non-profit (942)
North Carolina (291)
Northern California (401)
Obesity (135)
Ohio (48)
Opinion (166)
Patents (54)
Pennsylvania (238)
People (33148)
Pharmaceutical (63)
Phase I (13007)
Phase II (17774)
Phase III (14260)
Pipeline (73)
Podcasts (48)
Policy (53)
Postmarket research (1629)
Preclinical (4599)
Press Release (31)
Rare diseases (87)
Real estate (3236)
Regulatory (12233)
Research institute (840)
Resumes & cover letters (138)
South America (671)
Southern California (365)
Startups (2042)
Texas (98)
United States (3757)
Vaccines (184)
Washington State (97)
Weight loss (137)
Date
Today (87)
Last 7 days (348)
Last 30 days (1136)
Last 365 days (19184)
2024 (13306)
2023 (20227)
2022 (26876)
2021 (27725)
2020 (25733)
2019 (20627)
2018 (16031)
2017 (17777)
2016 (16586)
2015 (19279)
2014 (15162)
2013 (12797)
2012 (13779)
2011 (14147)
2010 (13085)
333,319 Results for "cytune pharma sas".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Outcome of Innate Pharma’s 2024 Annual General Meeting
Innate Pharma SA announced the voting results of its shareholders at the Annual General Meeting, which took place on May 23, 2024, in Marseille.
May 23, 2024
·
3 min read
Opinion
Opinion: A Small Pharma Mindset Can Reshape Big Pharma and Improve Patient Care
An appreciation for practicality, independent thinking and patient care can help disrupt the bureaucracy of Big Pharma.
September 12, 2024
·
3 min read
·
Jill Marie Drury
Innate Pharma Announces Its Participation in Upcoming June 2024 Investor Conferences
Regulatory News: Innate Pharma SA announced members of its executive team are scheduled to participate in the upcoming conferences, detailed below.
May 28, 2024
·
3 min read
Drug Development
Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Mycosis Fungoides
Innate Pharma SA announced favorable results from the Phase 2 TELLOMAK study with lacutamab in mycosis fungoides.
June 4, 2024
·
8 min read
Business
Innate Pharma Reports First Quarter 2024 Business Update and Financial Results
Innate Pharma SA reported its consolidated financial results for the quarter ending March 31, 2024.
May 14, 2024
·
12 min read
Innate Pharma: Clarification Regarding SAR443579 Designation
Innate Pharma SA announced that in an abstract published on 14 May 2024 for the European Hematology Association 2024 Congress on SAR443579/IPH6101, submitted by Sanofi, it was mentioned that the molecule received breakthrough designation.
May 21, 2024
·
4 min read
Drug Development
Celon Pharma Announces Results of Phase II clinical trial for CPL’ 116, a JAK/ROCK dual inhibitor in the treatment of Rheumatoid Arthritis (RA)
Celon Pharma S.A. (CLN.WA) today announced the successful completion of a Phase 2 trial a JAK/ROCK dual inhibitor in the treatment of Rheumatoid Arthritis (RA).
June 17, 2024
·
7 min read
Business
Astellas Pharma Opens Cambridge Life Sciences Center Featuring Incubator Space
Astellas Pharma’s new life sciences center houses its first U.S.-based SakuLab, an incubator space for external partners, as well as its engineered small molecules unit.
September 6, 2024
·
1 min read
·
Angela Gabriel
Innate Pharma Highlights Abstracts Selected for EHA 2024 Congress
Innate Pharma SA announced that four abstracts with Innate’s drug candidates have been accepted for the European Association of Hematology 2024 Congress, taking place June 13-16, 2024 in Madrid, Spain.
May 15, 2024
·
6 min read
Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting
Regulatory News: Innate Pharma SA announced that five abstracts with Innate’s drug candidates have been accepted for the American Society of Clinical Oncology 2024 Annual Meeting, taking place May 31-June 4, 2024 in Chicago, Illinois.
May 24, 2024
·
5 min read
1 of 33,332
Next
